Free Trial
→ War on Elon Escalates… (From Porter & Company) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 8 of 15

Slide 8
Back to 7
Continue to 9
 
Back to 7
Continue to 9
 

Arcellx (NASDAQ:ACLX)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
14 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$103.08 (17.4% Upside)

About Arcellx

Arcellx logoArcellx, Inc, together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/12/2024Truist FinancialBoost Price TargetBuy ➝ Buy$87.00 ➝ $136.00
11/8/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$91.00 ➝ $115.00
11/6/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$96.00 ➝ $96.00
11/6/2024HC WainwrightBoost Price TargetBuy ➝ Buy$80.00 ➝ $95.00
11/6/2024Robert W. BairdBoost Price TargetOutperform ➝ Outperform$77.00 ➝ $106.00
11/6/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$84.00 ➝ $100.00
11/6/2024Morgan StanleyBoost Price TargetOverweight ➝ Overweight$81.00 ➝ $106.00
10/31/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$96.00 ➝ $96.00
10/18/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$81.00 ➝ $96.00
10/18/2024Stifel NicolausBoost Price TargetBuy ➝ Buy$83.00 ➝ $122.00
Slide 8
Back to 7
Continue to 9
 

Election warning coming true… (Ad)

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

More From MarketBeat
Central Bank Abandons USD
Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...
True Gold Republic | Sponsored
7 Dividend Dynamos with a Yield of More Than 7%
Despite signs of a slowing economy, investors continue to climb the wall of worry. And let's face it, many of ...
MarketBeat
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?
Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...
Golden Crest | Sponsored
12 Cannabis Stocks to Buy Now
Slowly and surely the cannabis industry is becoming mainstream. As more states legalize medical and recreation...
MarketBeat
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...
Colonial Metals | Sponsored
10 Rock-Solid Dividend Paying Stocks to Add to Your Portfolio
While interest rates have risen over the last few years, there's still two things that fixed-income investment...
MarketBeat